In the last trading session, 4.9 million Petros Pharmaceuticals Inc (NASDAQ:PTPI) shares changed hands as the company’s beta touched 1.87. With the company’s per share
In the last trading session, 2.23 million Petros Pharmaceuticals Inc (NASDAQ:PTPI) shares changed hands as the company’s beta touched 2.03. With the company’s per share
In recent trading session, Petros Pharmaceuticals Inc (NASDAQ:PTPI) saw 1.1 million shares changing hands at last check today with its beta currently measuring 2.09. Company’s
Petros Pharmaceuticals Inc (NASDAQ:PTPI) has a beta value of 1.97 and has seen 12.27 million shares traded in the last trading session. The company, currently
Petros Pharmaceuticals Inc (NASDAQ:PTPI) has a beta value of 1.87 and has seen 18.89 million shares traded in the last trading session. The company, currently
During the last session, Petros Pharmaceuticals Inc (NASDAQ:PTPI)’s traded shares were 58.57 million, with the beta value of the company hitting 1.77. At the end
During the recent session, Petros Pharmaceuticals Inc (NASDAQ:PTPI)’s traded shares were 39.62 million, with the beta value of the company hitting 1.77. At the last
In the last trading session, 4.64 million shares of the Petros Pharmaceuticals Inc (NASDAQ:PTPI) were traded, and its beta was 2.07. Most recently the company’s
In the last trading session, 3.24 million shares of the Petros Pharmaceuticals Inc (NASDAQ:PTPI) were traded, and its beta was 2.05. Most recently the company’s
Petros Pharmaceuticals Inc (NASDAQ:PTPI)’s traded shares stood at 7.74 million during the last session, with the company’s beta value hitting 2.06. At the close of
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
